Jorina Langerveld

Tiel, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Journal: Circulation. Cardiovascular interventions

Published: February 26, 2026

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Journal: Circulation. Cardiovascular interventions

Published: February 26, 2026

Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry.

Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry.

Journal: Thrombosis and haemostasis

Published: October 29, 2024

Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome.

Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: September 17, 2024

Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study.

Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study.

Journal: European journal of heart failure

Published: April 05, 2024

Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients.

Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients.

Journal: JACC. Cardiovascular interventions

Published: January 28, 2024

Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry.

Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry.

Journal: Open heart

Published: June 30, 2023

Serum potassium level and mineralocorticoid receptor antagonist dose in a large cohort of chronic heart failure patients.

Serum potassium level and mineralocorticoid receptor antagonist dose in a large cohort of chronic heart failure patients.

Journal: ESC heart failure

Published: July 29, 2022

External validation of the GRACE risk score and the risk-treatment paradox in patients with acute coronary syndrome.

External validation of the GRACE risk score and the risk-treatment paradox in patients with acute coronary syndrome.

Journal: Open heart

Published: February 07, 2022

Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards "Personalized Medicine" in Daily Clinical Practice.

Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards "Personalized Medicine" in Daily Clinical Practice.

Journal: Journal of clinical medicine

Published: August 07, 2020

Medical treatment of octogenarians with chronic heart failure: data from CHECK-HF.

Medical treatment of octogenarians with chronic heart failure: data from CHECK-HF.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: November 04, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026